American Innovation and Jobs Act

Bill Number

S. 1639

Origin Chamber

Senate

Congress

119th Congress, Session 1

Policy Area

Taxation

Status

Introduced

Latest Action

2025-05-07: Read twice and referred to the Committee on Finance.

Last Updated

2025-06-06T18:13:36Z

AI-Generated Summary

Purpose

The American Innovation and Jobs Act (S. 1639) aims to boost innovation and economic growth by enhancing tax incentives for research and development (R&D) activities. It restores and expands deductions and credits under the Internal Revenue Code to encourage businesses, especially startups and small companies, to invest in R&D.

Key Provisions

• Immediate Expensing of R&D Costs (Section 2): Businesses can deduct research and experimental expenditures immediately in the year they are paid or incurred, rather than capitalizing and amortizing them over time. This applies to costs connected to a trade or business, excluding land improvements, depreciable property, or mineral exploration. Taxpayers can elect to amortize certain costs over at least 60 months if not fully expensed. The rules allow adoption without IRS consent for the first applicable year and require adherence unless changed with approval.
• Expanded Refundable Research Credit for Small Businesses (Section 3): Increases the cap on the refundable portion of the R&D tax credit (under Section 41) for new and small businesses. The cap starts at $500,000 for tax years beginning after December 31, 2024, and rises gradually to $750,000 by tax years beginning after December 31, 2034. Eligibility is extended from a 5-year to an 8-year period post-startup, and the gross receipts threshold for qualification is raised from $5 million to $15 million (with no more than $25,000 in excess of that in prior years).
• Improved Access to Research Credit for Startups (Section 4): Qualified small businesses (as defined under the existing credit rules) get a higher base rate for calculating the R&D credit: 20% instead of 14% of qualified research expenses over a fixed base amount. They can also elect a 10% rate (instead of 6%) for the growth portion or disregard years with no expenses when computing the average base.

Significant Changes to Existing Law

• Reverses the 2022 requirement under the Tax Cuts and Jobs Act that mandated amortization of R&D expenses over 5 years (or 15 years for foreign R&D), allowing full immediate deductions again as was the case before 2022.
• Boosts the refundable credit cap from a flat $250,000, introducing an inflation-adjusted escalation over a decade, and loosens eligibility criteria to include more startups.
• Enhances the alternative simplified credit method for small businesses, making it easier for them to claim larger credits without extensive historical data.
• Includes conforming amendments to coordinate with other tax rules, such as reducing deductions when credits are claimed and adjusting payroll tax credit provisions.

These changes apply retroactively for expensing (tax years after December 31, 2021) and prospectively for credits (after December 31, 2024, or enactment).

Potential Impacts

• On Businesses: Reduces tax liabilities for R&D-intensive companies, freeing up cash for further innovation. Small businesses and startups benefit most from expanded credits, potentially accelerating product development and job creation in tech, biotech, and manufacturing sectors.
• On Government Agencies: The IRS will need to update forms, guidance, and audits to handle increased claims and elections. This could raise federal revenue shortfalls initially (estimated in billions over 10 years) but promote long-term economic growth through innovation.
• On Citizens and Economy: Encourages broader participation in R&D, potentially leading to more U.S.-based jobs and technological advancements. No direct impact on international relations, though it may strengthen U.S. competitiveness against countries with similar incentives.
• Fiscal Effects: Likely increases tax expenditures (forgone revenue) but aims to stimulate GDP growth via higher R&D investment.

Main Stakeholders Affected

• Businesses, Especially Startups and Small Firms: Primary beneficiaries through easier access to deductions and higher refundable credits; large corporations also gain from restored expensing.
• Taxpayers in R&D Sectors: Includes tech, pharmaceuticals, engineering, and manufacturing companies conducting qualified research.
• IRS and Treasury Department: Responsible for implementation, elections, and enforcement.
• U.S. Economy and Workers: Indirectly affected via job growth and innovation in research-driven industries.

Notable Legal, Constitutional, or Political Implications

• Legal: Relies on Congress's taxing power under Article I of the Constitution; no challenges anticipated as it builds on existing Section 174 and 41 without altering core tax principles. Provides flexibility for IRS rulemaking on elections and reasonableness of expenses.
• Constitutional: Neutral, as it involves standard fiscal policy without impinging on individual rights.
• Political: Bipartisan support (introduced by a diverse group of senators) signals broad consensus on pro-innovation policies. Could influence future tax debates, especially around extending 2017 tax cuts, and faces scrutiny over revenue costs amid budget deficits. No major controversies, but implementation details may spark administrative law discussions.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Sen. Young, Todd [R-IN]

Cosponsors (35)

Sen. Hassan, Margaret Wood [D-NH], Sen. Lankford, James [R-OK], Sen. Shaheen, Jeanne [D-NH], Sen. Daines, Steve [R-MT], Sen. Warner, Mark R. [D-VA], Sen. Barrasso, John [R-WY], Sen. Rosen, Jacky [D-NV], Sen. Tillis, Thomas [R-NC], Sen. Peters, Gary C. [D-MI], Sen. Marshall, Roger [R-KS], Sen. Padilla, Alex [D-CA], Sen. Tuberville, Tommy [R-AL], Sen. Murray, Patty [D-WA], Sen. Kennedy, John [R-LA], Sen. Klobuchar, Amy [D-MN], Sen. Ricketts, Pete [R-NE], Sen. Kelly, Mark [D-AZ], Sen. Britt, Katie Boyd [R-AL], Sen. Kaine, Tim [D-VA], Sen. Capito, Shelley Moore [R-WV], Sen. Cortez Masto, Catherine [D-NV], Sen. Fischer, Deb [R-NE], Sen. Baldwin, Tammy [D-WI], Sen. Moran, Jerry [R-KS], Sen. Lujan, Ben Ray [D-NM], Sen. Hagerty, Bill [R-TN], Sen. Coons, Christopher A. [D-DE], Sen. Mullin, Markwayne [R-OK], Sen. Slotkin, Elissa [D-MI], Sen. Wicker, Roger F. [R-MS], Sen. King, Angus S., Jr. [I-ME], Sen. Budd, Ted [R-NC], Sen. Ossoff, Jon [D-GA], Sen. Husted, Jon [R-OH], Sen. Heinrich, Martin [D-NM]

Recent Actions

• 2025-05-07: Read twice and referred to the Committee on Finance.
• 2025-05-07: Introduced in Senate

Bill Versions

• American Innovation and Jobs Act — issued 2025-05-07 — PDF (14 pages)